ScreenerHero

NN6 NanoRepro AG

XETRA · DE · Healthcare · Diagnostics & Research · nanorepro.com
1.650EUR+0.92%Mkt Cap: 22.62M $P/E: —

NanoRepro AG engages in the development, manufacture, and distribution of rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. The company provides products in the are…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$242.77BUSDP/E 35.3
DHR
Danaher Corporation
$151.57BUSDP/E 38.4
NTRA
Natera, Inc.
$57.75BUSD
LONN
Lonza Group AG
$45.93BUSDP/E 38.2
A
Agilent Technologies, Inc.
$47.74BUSDP/E 33.4
WAT
Waters Corporation
$42.85BUSDP/E 110.5
IQV
IQVIA Holdings Inc.
$42.79BUSDP/E 32.3
ILMN
Illumina, Inc.
$41.30BUSDP/E 51.0
IDXX
IDEXX Laboratories, Inc.
$40.66BUSDP/E 36.2
MTD
Mettler-Toledo International Inc.
$30.72BUSDP/E 34.6
LH
Labcorp Holdings Inc.
$25.28BUSDP/E 25.8
DGX
Quest Diagnostics Incorporated
$25.21BUSDP/E 24.2
GH
Guardant Health, Inc.
$22.91BUSD
RVTY
Revvity, Inc.
$17.11BUSDP/E 73.3
MEDP
Medpace Holdings, Inc.
$16.83BUSDP/E 35.4
ERF
Eurofins Scientific SE
$14.16BUSDP/E 26.4
CRL
Charles River Laboratories International, Inc.
$14.56BUSD
ICLR
ICON Public Limited Company
$12.48BUSDP/E 170.2
BIM
bioMérieux S.A.
$10.27BUSDP/E 20.5
QGEN
Qiagen N.V.
$9.43BUSDP/E 23.2

Key Statistics

Company
Market Cap22.62M USD
Enterprise Value13.43M USD
Revenue (TTM)4.71M USD
Gross Profit3.20M USD
Net Income (TTM)-2.22M USD
Revenue/Share0.34 EUR
Last Price1.650 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees22
CountryDE
SectorHealthcare
IndustryDiagnostics & Research
ISINDE0006577109
Valuation
P/E (Trailing)—
P/E (Forward)-53.17
PEG—
EV/EBITDA-6.04
EV/Revenue2.85
P/S4.64
P/B0.56
EPS (TTM)-0.14
EPS (Forward)-0.03
52W Range
1.31031% of range2.400
52W High2.400 EUR
52W Low1.310 EUR
Profitability
Gross Margin63.38%
Oper. Margin-60.04%
EBITDA Margin-47.20%
Profit Margin-44.02%
ROE-5.36%
ROA-5.24%
Growth
Revenue Growth-29.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF10.72M USD
CapEx (TTM)437.61K USD
FCF Margin—
FCF Yield—
Net Debt-8.44M USD
Net Debt/EBITDA3.79
Balance Sheet
Debt/Equity—
Current Ratio36.72
Quick Ratio33.08
Book Value/Sh2.87 EUR
Cash/Share0.61 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 EUR
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio160.81%
Ex-Div DateJun 16, 2023
Pay Date—
Analyst Consensus
Rating—
Target (Mean)4.450 EUR
Upside (mean)+169.7%
Target Range4.400 EUR – 4.500 EUR
4.400+169.7% to mean4.500
# Analysts2
Ownership
Shares Out.12.61M
Float—
Insiders2.00%
Institutions9.33%
Technical
SMA 501.823 (-9.5%)
SMA 2001.694 (-2.6%)
Beta0.46
S&P 52W Chg14.58%
Avg Vol (30d)6.61K
Avg Vol (10d)4.86K
Technical Indicators
RSI (14)43.4
MACD-0.0518
MACD Signal-0.0534
MACD Hist.+0.0015
BB Upper1.811 EUR
BB Middle1.692 EUR
BB Lower1.574 EUR
BB Width13.95%
ATR (14)0.0895 EUR
Vol Ratio (20d)0.21x